PremiumCompany AnnouncementsOnconetix Appoints Karina Fedasz as Interim CEO Onconetix Delays Yearly Report Filing Onconetix claims validation of prostate cancer test Proclarix in Danish cohort PremiumCompany AnnouncementsOnconetix Announces Promissory Note Agreement with Keystone Biotech Alert: Searches spiking for these stocks today Biotech Alert: Searches spiking for these stocks today PremiumCompany AnnouncementsOnconetix Secures Funding to Enhance Operations and Growth Onconetix rallies after Altos Venture reports 32.5% stake Onconetix Inc trading halted, news pending